Australia has lead the world in it’s management of the Hepatitis C virus (HCV), with the government making direct acting antiviral (DAA) medication available for anyone living with HCV under the pharmaceutical benefits scheme.
Depending on the genotype of Hepatitis C, it may be a combinaiton of 2 or 3 antiviral medications.
Recently there has been a pan-genotype DAA under the PBS which is a combination of sofosbuvir/velpatasvir.
Treatment is typically for 12 weeks, but may be up to 24 weeks in people who have had treatment before, or are suffering from cirrhosis.
At your first appointment with one of our doctors, we’ll go through your previous medical and surgical history, and your history of Hepatitis C.
We’ll do an examination, and order some blood tests including a full blood count, kidney and liver function tests, and a HCV viral load.
We also need to see if you likely have cirrhosis, and if the test results are suggestive a fibroscan test will be needed. If there is severe cirrhosis a referral to a gastroenterologist may be required.
Once these test results have returned we can commence treatment.
The new DAA class of medicines are not only better tolerated, but have a 90-95% cure rate for most people, and for most people are interferon free.
Your appointments at GSHealth are at the regular appointment rates. If you’re a new patient a long consult (30 minutes) is suggested at first, and there will be several follow up appointments that may be shorter.
The medication itself is funded by the PBS, so it only costs $38.30 for general patients and $6.20 for concessional patients.
Green Square Health provides a range of services to fulfil the needs of our community.
Please find more information on the pages below about our services and tips on how to stay healthy.